The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Open accessAbstract
Carbapenem-resistant Enterobacteriaceae (CRE) are a serious public health threat. Infections due to these organisms are associated with significant morbidity and mortality. Mechanisms of drug resistance in gram-negative bacteria (GNB) are numerous; β-lactamase genes carried on mobile genetic elements are a key mechanism for the rapid spread of antibiotic-resistant GNB worldwide. Transmissible carbapenem-resistance in Enterobacteriaceae has been recognized for the last 2 decades, but global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) is a more recent problem that, once initiated, has been occurring at an alarming pace. In this article, we discuss the evolution of CRE, with a focus on the epidemiology of the CPE pandemic; review risk factors for colonization and infection with the most common transmissible CPE worldwide, Klebsiella pneumoniae carbapenemase-producing K. pneumoniae; and present strategies used to halt the striking spread of these deadly pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.007 · Cited by 3,456
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Nucleic acid-based approaches to investigate microbial-related cheese quality defects
O'Sullivan, D. J., Giblin, L., McSweeney, P. L. H., Sheehan, J. J., & Cotter, P. D. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00001 · Cited by 1,417
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M., & Chiarello, L. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,283
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Resistance Plasmid Families in Enterobacteriaceae
Carattoli, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-08 · Cited by 1,229
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Vital signs: carbapenem-resistant Enterobacteriaceae.
(2013) · PubMed Central · Cited by 603
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.891-897.2000 · Cited by 562
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Chen, L., Mathema, B., Chavda, K. D., DeLeo, F. R., Bonomo, R. A., & Kreiswirth, B. N. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.09.003 · Cited by 554
Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A., & Giske, C. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-09 · Cited by 522
Emerging carbapenemases: a global perspective
Walsh, T. R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(10)70004-2 · Cited by 506
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Dortet, L., Poirel, L., & Nordmann, P. (2014) · BioMed Research International · doi:10.1155/2014/249856 · Cited by 501
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
“Stormy waters ahead”: global emergence of carbapenemases
Patel, G., & Bonomo, R. A. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00048 · Cited by 423
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Guh, A. Y., Bulens, S. N., Mu, Y., Jacob, J. T., Reno, J., Scott, J., Wilson, L. E., Vaeth, E., Lynfield, R., Shaw, K. M., et al. (2015) · JAMA · doi:10.1001/jama.2015.12480 · Cited by 369
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Souli, M., Galani, I., Antoniadou, A., Papadomichelakis, E., Poulakou, G., Panagea, T., Vourli, S., Zerva, L., Armaganidis, A., Kanellakopoulou, K., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649865 · Cited by 271
Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayankun, R., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.824 · Cited by 266
Leavitt, A., Navon-Venezia, S., Chmelnitsky, I., Schwaber, M. J., & Carmeli, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00299-07 · Cited by 256
Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids
Haenni, M., Poirel, L., Kieffer, N., Châtre, P., Saras, E., Métayer, V., Dumoulin, R., Nordmann, P., & Madec, J.-Y. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00007-4 · Cited by 256
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
Falagas, M. E., Rafailidis, P. I., Kofteridis, D. P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm356 · Cited by 253
Virginia Villegas, M., Lolans, K., Correa, A., Jose Suarez, C., Lopez, J. A., Vallejo, M., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00186-06 · Cited by 232
Lin, M. Y., Lyles-Banks, R. D., Lolans, K., Hines, D. W., Spear, J. B., Petrak, R., Trick, W. E., Weinstein, R. A., Hayden, M. K., Acuna, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit500 · Cited by 226
Self-citationCarbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
Temkin, E., Adler, A., Lerner, A., & Carmeli, Y. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12537 · Cited by 223
B1-Metallo-β-Lactamases: Where Do We Stand?
F. Mojica, M., A. Bonomo, R., & Fast, W. (2016) · Current Drug Targets · doi:10.2174/1389450116666151001105622 · Cited by 215
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
Thomson, J. M., & Bonomo, R. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.014 · Cited by 212
Cuzon, G., Naas, T., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05202-11 · Cited by 210
Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain
Chen, L., Mathema, B., Pitout, J. D. D., DeLeo, F. R., & Kreiswirth, B. N. (2014) · mBio · doi:10.1128/mbio.01355-14 · Cited by 209
Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli
Poirel, L., Kieffer, N., Liassine, N., Thanh, D., & Nordmann, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00006-2 · Cited by 208
Andrade, L. N., Curiao, T., Ferreira, J. C., Longo, J. M., Clímaco, E. C., Martinez, R., Bellissimo-Rodrigues, F., Basile-Filho, A., Evaristo, M. A., Del Peloso, P. F., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01783-10 · Cited by 194
Perry, J. D., Naqvi, S. H., Mirza, I. A., Alizai, S. A., Hussain, A., Ghirardi, S., Orenga, S., Wilkinson, K., Woodford, N., Zhang, J., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr299 · Cited by 188
Carbapenem-Resistant Enterobacteriaceae: An Emerging Problem in Children
Logan, L. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis543 · Cited by 170
Self-citationMunoz-Price, L. S., Hayden, M. K., Lolans, K., Won, S., Calvert, K., Lin, M., Sterner, A., & Weinstein, R. A. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651097 · Cited by 167
Self-citationLascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
Kitchel, B., Rasheed, J. K., Endimiani, A., Hujer, A. M., Anderson, K. F., Bonomo, R. A., & Patel, J. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00008-10 · Cited by 154
Deshpande, L. M., Rhomberg, P. R., Sader, H. S., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.004 · Cited by 149
Pereira, P. S., de Araújo, C. F. M., Seki, L. M., Zahner, V., Carvalho-Assef, A. P. D., & Asensi, M. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks396 · Cited by 146
Carbapenem-ResistantEnterobacteriaceaein Children, United States, 1999–2012
Logan, L. K., Renschler, J. P., Gandra, S., Weinstein, R. A., & Laxminarayan, R. (2015) · Emerging infectious diseases · doi:10.3201/eid2111.150548 · Cited by 142
Self-citationTrends in antimicrobial resistance in intensive care units in the United States
Prabaker, K. K., & Weinstein, R. A. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32834a4b03 · Cited by 99
Self-citationPrabaker, K. K., Lin, M. Y., McNally, M., Cherabuddi, K., Ahmed, S. S., Norris, A., Lolans, K., Odeh, R. M., Chundi, V. V., Weinstein, R. A., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668435 · Cited by 99
Self-citationViau, R. A., Hujer, A. M., Marshall, S. H., Pérez, F., Hujer, K. M., Briceno, D. F., Dul, M. J., Jacobs, M. R., Grossberg, R., Toltzis, P., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis036 · Cited by 79
Carbapenem-Resistant Enterobacteriaceae Infections in Children
Chiotos, K., Han, J., & Tamma, P. D. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0510-9 · Cited by 78
Pannaraj, P. S., Bard, J. D., Cerini, C., & Weissman, S. J. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000471 · Cited by 75
Mills, J., Talati, N. J., Alby, K., & Han, J. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2015.254 · Cited by 64
Kaiser, R., Castanheira, M., Jones, R. N., Tenover, F. C., & Lynfield, R. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.03.032 · Cited by 57
Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia
Mojica, M. F., Correa, A., Vargas, D. A., Maya, J. J., Montealegre, M. C., Rojas, L. J., Ruiz, S. J., Quinn, J. P., & Villegas, M. V. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.05.006 · Cited by 45
Rhomberg, P. R., Deshpande, L. M., Kirby, J. T., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.05.009 · Cited by 41
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA
Trick, W. E., Lin, M. Y., Leidig, R. C., Driscoll, M., Tang, A. S., Gao, W. D., Runningdeer, E., Arwady, M. A., & Weinstein, R. A. (2015) · Emerging infectious diseases · doi:10.3201/eid2110.150538 · Cited by 39
Self-citationOutbreak of KPC-3 Producing Carbapenem-Resistant Klebsiella pneumoniae in a US Pediatric Hospital
Stillwell, T. L., Green, M., Barbadora, K. A., Ferrelli, J. G., Roberts, T. L., Weissman, S. J., & Nowalk, A. J. (2014) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piu080 · Cited by 38
Metallo-β-Lactamase (MBL)-Producing Enterobacteriaceae in United States Children
Logan, L. K., & Bonomo, R. A. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw090 · Cited by 37
Self-citationCurrent status of carbapenemases in Latin America
Maya, J. J., Ruiz, S. J., Blanco, V. M., Gotuzzo, E., Guzmán-Blanco, M., Labarca, J. A., Salles, M. J. C., Quinn, J. P., & Villegas, M. V. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.811924 · Cited by 35
Bacteremia in Early Infancy: Etiology and Management
Cantey, J. B., Farris, A. C., & McCormick, S. M. (2015) · Current Infectious Disease Reports · doi:10.1007/s11908-015-0508-3 · Cited by 24
Suwantarat, N., Logan, L. K., Carroll, K. C., Bonomo, R. A., Simner, P. J., Rudin, S. D., Milstone, A. M., Tekle, T., Ross, T. L., & Tamma, P. D. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.16 · Cited by 24
Self-citation
Cited by
β-Lactamases and β-Lactamase Inhibitors in the 21st Century
Tooke, C. L., Hinchliffe, P., Bragginton, E. C., Colenso, C. K., Hirvonen, V. H. A., Takebayashi, Y., & Spencer, J. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.002 · Cited by 1,016
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Past and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Impact of Vaccines; Health, Economic and Social Perspectives
Rodrigues, C. M. C., & Plotkin, S. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01526 · Cited by 737
Metadata
- Authors
- Logan, L. K., & Weinstein, R. A.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-15
- Volume
- 215
- Issue
- suppl_1
- Pages
- S28-S36
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2603039590
- Cited by
- 1,584
- References
- 77
- FWCI
- 44.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.